Qiagen N.V. entered into a partnership with Freenome, a leading artificial intelligence (AI) genomics company, to accelerate the development and commercialization of next-generation sequencing (NGS) tests...
Roche and Foundation Medicine, Inc. have entered into a definitive merger agreement for Roche to acquire the outstanding shares of FMI’s common stock not already owned...
Agilent Technologies, Inc. has entered into a definitive agreement to acquire all the business assets of Ultra Scientific, a leading provider of chemical standards and certified...
PerkinElmer, Inc. has acquired Shanghai Spectrum Instruments Co., Ltd. (SSI), one of the leading manufacturers of analytical instruments in China. This acquisition helps the company to...
Bristol-Myers Squibb Company and Illumina Inc. have entered into a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally commercialize in-vitro diagnostic...
Abbott has initiated a clinical trial evaluating long-term outcomes of patients who undergo stent implantation guided by high-resolution light-based imaging technology – called optical coherence tomography...
Agilent Technologies Inc. and BioTek Instruments Inc. have joined forces to create a new, integrated solution that combines cellular metabolic analysis and imaging technologies. The optimized...
Thermo Fisher Scientific has acquired IntegenX Inc, which provides a rapid DNA platform for use in forensics and law enforcement applications. IntegenX products significantly enhance Thermo...
Sysmex offers Caresphere, a new network solution that supports the efforts of people involved in testing and healthcare, such as increasing levels of operating efficiency, quality,...
Qiagen NV and Natera Inc. have partnered to develop cutting-edge cell-free DNA assays for use on QIAGEN’s GeneReader NGS system. These cell-free DNA assays will now...
Copyright © 2025 Medical Buyer maintained by Fullstack development